| 摘要 |
The present invention provides a pharmaceutical product for combating cancer with vincristine as active constituent, the neuropathic complications being prevented by a peptide. The product according to the invention contains: (a) vincristine or a salt thereof, and (b) a peptide having the general formula I: lH-L-Met(X)-L-Glu-L-His-L-Phe-A-B-Y or a salt or an N-acyl derivative thereof in which Met(X) represents the amino acid radical Met, Met(0) or Met(O2), A represents the amino acid radical L-Lys, D-Lys, L-Arg or D-Arg, B represents the amino acid radical L-Trp or L-Phe, Y represents the hydroxyl group, an esterified hydroxyl group or an optionally substituted amino group. t |
